Augustin Guédénon

1.1k total citations
19 papers, 794 citations indexed

About

Augustin Guédénon is a scholar working on Epidemiology, Small Animals and Surgery. According to data from OpenAlex, Augustin Guédénon has authored 19 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 14 papers in Small Animals and 9 papers in Surgery. Recurrent topics in Augustin Guédénon's work include Mycobacterium research and diagnosis (18 papers), Infectious Diseases and Mycology (14 papers) and Infectious Diseases and Tuberculosis (8 papers). Augustin Guédénon is often cited by papers focused on Mycobacterium research and diagnosis (18 papers), Infectious Diseases and Mycology (14 papers) and Infectious Diseases and Tuberculosis (8 papers). Augustin Guédénon collaborates with scholars based in Belgium, Benin and United States. Augustin Guédénon's co-authors include Françoise Portaels, Claude Zinsou, Wayne M. Meyers, C. Steunou, Christian Johnson, Martine Debacker, J. Aguiar, Pim de Rijk, Hans De Beenhouwer and Marie-Françoise Ardant and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Augustin Guédénon

19 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Augustin Guédénon Belgium 14 740 462 417 163 48 19 794
Martine Debacker Belgium 12 617 0.8× 362 0.8× 394 0.9× 160 1.0× 41 0.9× 18 697
Samuel Etuaful Ghana 15 889 1.2× 580 1.3× 374 0.9× 197 1.2× 32 0.7× 17 956
C. Steunou Belgium 9 536 0.7× 352 0.8× 306 0.7× 114 0.7× 41 0.9× 9 571
Edwin Ampadu Ghana 13 740 1.0× 466 1.0× 326 0.8× 159 1.0× 33 0.7× 24 794
Valeria Penati Italy 14 551 0.7× 107 0.2× 503 1.2× 232 1.4× 56 1.2× 22 629
Marinka Kartalija United States 10 326 0.4× 99 0.2× 279 0.7× 60 0.4× 57 1.2× 11 518
Natalie Williams‐Bouyer United States 10 311 0.4× 119 0.3× 268 0.6× 96 0.6× 19 0.4× 26 428
M Kubín Czechia 12 366 0.5× 81 0.2× 288 0.7× 87 0.5× 32 0.7× 50 470
Ange Dodji Dossou Benin 11 261 0.4× 151 0.3× 132 0.3× 53 0.3× 10 0.2× 21 322
A. Lavy Israel 8 350 0.5× 142 0.3× 251 0.6× 81 0.5× 9 0.2× 11 402

Countries citing papers authored by Augustin Guédénon

Since Specialization
Citations

This map shows the geographic impact of Augustin Guédénon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Augustin Guédénon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Augustin Guédénon more than expected).

Fields of papers citing papers by Augustin Guédénon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Augustin Guédénon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Augustin Guédénon. The network helps show where Augustin Guédénon may publish in the future.

Co-authorship network of co-authors of Augustin Guédénon

This figure shows the co-authorship network connecting the top 25 collaborators of Augustin Guédénon. A scholar is included among the top collaborators of Augustin Guédénon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Augustin Guédénon. Augustin Guédénon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chauty, Annick, Marie-Françoise Ardant, Ambroise Adeye, et al.. (2007). Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( Mycobacterium ulcerans Disease). Antimicrobial Agents and Chemotherapy. 51(11). 4029–4035. 156 indexed citations
2.
Johnson, Roch Christian, et al.. (2004). Le traitement traditionnel de l'ulcère de Buruli au Bénin. 64(2). 145–150. 14 indexed citations
3.
Debacker, Martine, Julia Aguiar, C. Steunou, et al.. (2004). Mycobacterium ulceransDisease (Buruli Ulcer) in Rural Hospital, Southern Benin, 1997–2001. Emerging infectious diseases. 10(8). 1391–1398. 110 indexed citations
4.
Stienstra, Ymkje, Pieter U. Dijkstra, Augustin Guédénon, et al.. (2004). DEVELOPMENT OF A QUESTIONNAIRE ASSESSING BURULI ULCER–INDUCED FUNCTIONAL LIMITATION. American Journal of Tropical Medicine and Hygiene. 70(3). 318–322. 21 indexed citations
5.
Jossé, R, et al.. (2004). L'ulcère de Buruli en 2004. 1 indexed citations
6.
Makoutodé, Michel, et al.. (2004). [Traditional treatment for Buruli ulcer in Benin].. PubMed. 64(2). 145–50. 13 indexed citations
7.
Jossé, R, et al.. (2004). [Buruli ulcer in 2004].. PubMed. 64(2). 133–5. 1 indexed citations
8.
Clercq, Erik De & Augustin Guédénon. (2004). Leprosy in Africa: a contrasted picture.. PubMed. 75(4). 306–9. 2 indexed citations
9.
Aujoulat, Isabelle, Christian Johnson, Claude Zinsou, Augustin Guédénon, & Françoise Portaels. (2003). Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Tropical Medicine & International Health. 8(8). 750–759. 87 indexed citations
10.
Portaels, Françoise, J. Aguiar, Martine Debacker, et al.. (2003). Mycobacterium bovis BCG Vaccination as Prophylaxis against Mycobacterium ulcerans Osteomyelitis in Buruli Ulcer Disease. Infection and Immunity. 72(1). 62–65. 87 indexed citations
11.
Portaels, F., Claude Zinsou, J. Aguiar, et al.. (2003). Les atteintes osseuses dans l'ulcère de Buruli: à propos de 73 cas. 16 indexed citations
12.
Portaels, Françoise, J. Aguiar, Martine Debacker, et al.. (2002). Prophylactic Effect ofMycobacterium bovisBCG Vaccination against Osteomyelitis in Children withMycobacterium ulceransDisease (Buruli Ulcer). Clinical and Vaccine Immunology. 9(6). 1389–1391. 48 indexed citations
13.
Aguiar, Julia, et al.. (2000). Mycobacterium ulcerans infection (buruli ulcer): A case report of the disseminated nonulcerative form. Annals of Diagnostic Pathology. 4(6). 386–390. 16 indexed citations
14.
Aguiar, J., Marc-Christian Domingo, Augustin Guédénon, et al.. (1997). L'ulcère de Buruli, une maladie mycobactérienne importante et en recrudescence au Bénin. 325–356. 21 indexed citations
15.
Portaels, Françoise, K. Fissette, Pierre-Alain Fonteyne, et al.. (1997). Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. Journal of Clinical Microbiology. 35(5). 1097–1100. 73 indexed citations
16.
Portaels, Françoise, et al.. (1996). Variability in 3' end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates. Journal of Clinical Microbiology. 34(4). 962–965. 93 indexed citations
17.
Jossé, R, et al.. (1995). [Mycobacterium ulcerans cutaneous infections: Buruli ulcers].. PubMed. 55(4). 363–73. 20 indexed citations
18.
Jossé, R, Augustin Guédénon, J. Aguiar, et al.. (1994). [Buruli's ulcer, a pathology little known in Benin. Apropos of 227 cases].. PubMed. 87(3). 170–5. 12 indexed citations
19.
Jossé, R, et al.. (1992). Étude clinique et épidémiologique de l’ulcère de Buruli chez le jeune au Bénin. Cahiers d'études et de recherches francophones / Santé. 2(1). 23–27. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026